Sale!

Buy Auvelity, 45 – 105 MG Extended Release at Rs 10000/box

Original price was: $500.00.Current price is: $450.00.

💊 Auvelity 45-105 mg – Fast-Acting Relief for Major Depressive Disorder (MDD)

Auvelity 45-105 mg is a breakthrough prescription medication used for the treatment of major depressive disorder (MDD) in adults. It is the first and only oral NMDA receptor antagonist approved for MDD, offering rapid-acting antidepressant effects—often within one week of starting treatment.

Auvelity contains a unique combination of dextromethorphan HBr (45 mg) and bupropion HCl (105 mg). Dextromethorphan works as an NMDA receptor antagonist, helping to rebalance brain neurotransmitters, while bupropion boosts dopamine and norepinephrine levels, enhancing mood and energy.

Why Choose Auvelity 45-105 mg?

To begin with, Auvelity is ideal for patients who haven’t experienced fast relief with traditional antidepressants. Unlike standard SSRIs or SNRIs, which may take several weeks to show results, Auvelity often begins working within 7 days, providing faster emotional relief and better mood stabilization.

Moreover, Auvelity is well-suited for long-term treatment and does not require intravenous or in-office administration. It’s taken orally, once daily, for ease and convenience.

Key Benefits

  • ✅ Rapid symptom relief—often within 1 week

  • ✅ First oral NMDA receptor antagonist for depression

  • ✅ Treats major depressive disorder effectively

  • ✅ Convenient once-daily oral capsule

  • ✅ Combines two proven ingredients for enhanced results

How to Use

Take one Auvelity 45-105 mg capsule daily, with or without food, as prescribed by your healthcare provider. Do not crush or chew the capsule. Follow the prescribed dosage schedule for safe, effective results.

⚠️ Always consult your doctor before starting, stopping, or combining Auvelity with other medications.

Description

💊 Auvelity 45-105 mg – Fast-Acting Oral Antidepressant for Major Depressive Disorder (MDD)

Auvelity 45-105 mg is a prescription medication developed for the treatment of major depressive disorder (MDD) in adults. It’s the first and only oral NMDA receptor antagonist approved by the FDA for depression, offering a unique dual-action formula that can deliver significant symptom relief within one week—far quicker than many traditional antidepressants.

This innovative medication combines two active ingredients:

  • Dextromethorphan HBr (45 mg) – works on NMDA receptors in the brain, helping rebalance key neurotransmitters involved in mood regulation.

  • Bupropion HCl (105 mg) – a dopamine and norepinephrine reuptake inhibitor (DNRI) that further supports emotional stability and energy levels.

How Does Auvelity Work?

Unlike SSRIs and SNRIs, which often take 4–6 weeks to show full results, Auvelity acts rapidly, thanks to the combined mechanism of NMDA modulation and dopaminergic support. This dual pathway approach enhances synaptic plasticity and neurochemical balance, which may contribute to the faster relief of depressive symptoms.

Benefits of Auvelity 45-105 mg

  • ✅ Rapid onset—relief often felt in 7 days

  • ✅ Treats symptoms of MDD effectively

  • ✅ First-of-its-kind oral NMDA receptor antagonist

  • ✅ Once-daily capsule for convenience

  • ✅ Ideal for patients with inadequate SSRI/SNRI response

  • ✅ Improves mood, motivation, and mental clarity

How to Take Auvelity

Take one capsule daily by mouth, with or without food. Swallow the capsule whole; do not crush, chew, or split it. Always follow your healthcare provider’s instructions. Do not use in combination with MAOIs or other forms of bupropion unless specifically prescribed.

⚠️ Important: Auvelity is a prescription-only medication. Always consult your doctor before starting or discontinuing treatment. Be aware of potential side effects, including dizziness, dry mouth, or increased blood pressure.

Reviews

There are no reviews yet.

Be the first to review “Buy Auvelity, 45 – 105 MG Extended Release at Rs 10000/box”

Your email address will not be published. Required fields are marked *